Mental wellbeing and older people Public Health Intervention Guidance PH16 (22nd October 2008)
The guidance focuses on the role of occupational therapy interventions and physical activity interventions in the promotion of mental wellbeing for older people. It is for NHS primary care and other professionals who have a direct or indirect role in, and responsibility for, promoting older people's mental wellbeing. This includes those working in local authorities and the wider public, private, voluntary and community sectors. It will also be relevant for carers and family members who support older people and may be of interest to older people themselves. The guidance complements and supports, but does not replace, NICE guidance on: supporting people with dementia and their carers in health and social care; managing depression in primary and secondary care; assessing and preventing falls in older people; obesity; commonly used methods to increase physical activity; physical activity and the environment; behaviour change and community engagement.
Guidance
Quick Reference Guide
Costing Report
Pain (chronic neuropathic or ischaemic) - spinal cord stimulation Technology Appraisal TA159 (22nd October 2008)
Spinal cord stimulation is recommended as a possible treatment for adults with chronic pain of neuropathic origin if they: continue to experience chronic pain (measuring at least 50 mm on a 0–100 mm visual analogue scale) for at least 6 months despite standard treatments, and have had a successful trial of spinal cord stimulation as part of an assessment by a specialist team. Treatment with spinal cord stimulation should only be given after the person has been assessed by a specialist team experienced in assessing and managing people receiving treatment with spinal cord stimulation.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Audit Support
Costing Template
Surgical site infection Clinical Guideline CG74 (22nd October 2008)
The advice in the NICE guideline covers: adults and children who are going to have a cut through the skin for an operation. It does not specifically look at: adults and children who are going to have an operation that does not involve a cut through the skin on the outside of the body; and adults and children who are going to have procedures involving thin tubes (called catheters) placed in blood vessels, tubes (called shunts) inserted into the body to divert fluid, thin flexible telescopes (called endoscopes) to view the inside of the body or metal pins used externally to treat broken bones. This guideline updates and replaces NICE technology appraisal guidance 24 (published April 2001).
NICE Guideline
Full Guideline
Full Guideline - Search Strategies
Full Guideline - Excluded Studies
Full Guideline - Evidence Tables
Quick Reference Guide
Understanding NICE Guidance
Costing Statement
Osteoporosis - primary prevention Technology appraisal TA160 (22th October 2008)
Whether or not a postmenopausal woman with osteoporosis is offered one of these drugs to prevent bone fractures will depend on her age, her bone density and how many risk factors for fracture and indicators of fragile bones she has. In principle, alendronate is recommended as a possible treatment for preventing bone fractures in postmenopausal women who have had osteoporosis diagnosed but have not had a fracture. If a woman can't take alendronate, risedronate and etidronate are recommended under certain circumstances as possible alternative treatments to prevent fractures. If a woman can't take alendronate or either risedronate or etidronate, then strontium ranelate is recommended under certain circumstances as a possible alternative treatment to prevent fractures. Raloxifene is not recommended as a treatment for preventing fractures in postmenopausal women with osteoporosis who have not had a fracture. The guidance says that women who are 75 or over may not need a bone scan to diagnose their osteoporosis.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Osteoporosis - secondary prevention including strontium ranelate Technology appraisal TA161 (29th October 2008)
Whether or not a postmenopausal woman who has had a bone fracture because of osteoporosis is offered treatment to prevent further fractures will depend on her age, her bone density and how many risk factors for fracture she has. Alendronate is recommended as a possible treatment for preventing bone fractures in postmenopausal women who have already had a fracture and have had osteoporosis diagnosed. If a woman can't take alendronate, risedronate and etidronate are recommended under certain circumstances as possible alternative treatments to prevent further fractures. If a woman can't take alendronate or either risedronate or etidronate, then strontium ranelate and raloxifene are recommended under certain circumstances as possible alternative treatments to prevent further fractures. If a woman can't take alendronate, or either risedronate or etidronate, or strontium ranelate, teriparatide is recommended under certain circumstances as a possible alternative treatment to prevent further fractures. Teriparatide is also recommended as a possible alternative treatment for a woman who has another fracture when she has been taking alendronate, risedronate or etidronate for 1 year (and her bone density has fallen). The guidance says that women who are 75 or over may not need a bone scan to diagnose their osteoporosis.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Management of long-term sickness absence and incapacity for work: consultation on the additional evidence (20th October 2008)
NICE was asked by the Department of Health (DH) to develop guidance for the NHS and other organisations in the public, community, voluntary and private sectors on: ‘the management of long-term sickness absence and incapacity'. In addition to the four evidence reviews and economic appraisal which were consulted on in May and June 2008 two reports and five expert papers have also been considered by the Programme Development Group (PDG) on long-term sickness absence and incapacity. Closing date for comments is 17th November 2008.
Consultation
Multiple myeloma - lenalidomide: appraisal consultation (28th October 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of lenalidomide and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of lenalidomide. Closing date for comments is 18th November 2008.
Consultation
Evaluation Report
Interventional procedures consultation document - intraocular lens insertion for correction of refractive error, with preservation of the natural lens (28th October 2008)
Short-sightedness is the inability to see clearly at a distance. Eyesight can usually be corrected by wearing spectacles or contact lenses. Insertion of a clear plastic lens in front of the existing lens is a procedure that aims to improve vision in short-sightedness. Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultation document - laparoscopic cystectomy (28th October 2008)
Laparoscopic cystectomy involves removing the bladder using small cuts (also known as 'keyhole surgery'). In women, the bladder is removed through the wall of the vagina. In men, the bladder is removed with the prostate gland, through a small cut in the wall of the abdomen. The tubes that carry urine from the kidneys to the bladder (the ureters) may then be connected to a bag worn outside the body, or parts of the bowel can be used to make an artificial bladder which is drained by a connection to the abdomen wall or to the tube that carries urine out of the body (the urethra). Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultations document - extracorporeal photopheresis for Crohn’s disease (28th October 2008)
Crohn's disease is a chronic inflammatory disease that affects the gastrointestinal tract. It is sometimes associated with other complications such as skin rashes and arthritis. In extracorporeal photopheresis blood is removed from the patient, then the white blood cells are separated from the whole blood, treated with ultraviolet light and re-infused into the patient. Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultation document for percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia (28th October 2008)
Ventricular tachycardia is a life-threatening heart condition. It occurs when the electrical impulses controlling the heartbeat become erratic, causing the heart to beat too quickly. When this happens, the heart cannot efficiently pump blood around the body. Ventricular tachycardia, if left untreated, may cause sudden cardiac death. In percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation, selected areas on the outside of the heart are destroyed using heat, with the aim of preventing abnormal electrical impulses responsible for ventricular tachycardia from occurring. The procedure is carried out by inserting a special catheter into the sac around the heart and using it to deliver heat to selected areas of heart muscle where abnormal electrical impulses responsible for the ventricular tachycardia are detected. Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultation document - percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation (28th October 2008)
Laparoscopic cystectomy involves removing the bladder using small cuts (also known as 'keyhole surgery'). In women, the bladder is removed through the wall of the vagina. In men, the bladder is removed with the prostate gland, through a small cut in the wall of the abdomen. The tubes that carry urine from the kidneys to the bladder (the ureters) may then be connected to a bag worn outside the body, or parts of the bowel can be used to make an artificial bladder which is drained by a connection to the abdomen wall or to the tube that carries urine out of the body (the urethra). Closing date for comments is 25th November 2008.
Consultation
Strategies to prevent unintentional injuries among under 15s: draft scope consultation (3rd November 2008)
NICE is developing public health guidance (using the programme development process) to prevent unintentional injuries among children and young people aged under 15. Closing date for comments is 1st December 2008.
Consultation
Preventing unintentional injuries among under 15s in the home: consultation on the draft scope (3rd November 2008)
NICE is developing public health intervention guidance preventing unintentional injuries from fire, hot fluids, electric sockets and heat- generating appliances in the home among children and young people aged under 15. Closing date for comments is 1st December 2008.
Consultation
Preventing unintentional road injuries among under 15s: consultation on the draft scope (3rd November 2008)
NICE is developing public health intervention guidance on road design to prevent unintentional injuries among children and young people aged under 15. Closing date for comments is 1st December 2008.
Consultation
Appraising end of life medicines (4th November 2008)
NICE would like to receive comments on the proposal to issue supplemental advice to its Appraisal Committees, in the form of an amendment to its Guide to the Methods of Technology Appraisal. Closing date for comments is 10th December 2008.
Consultation
Critical illness rehabilitation: consultation on draft guidance (7th November 2008)
A clinical practice guideline on Critical illness rehabilitation is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 5th December 2008.
Consultation
Lung cancer - update: consultation on the draft scope (7th November 2008)
NICE have been asked to develop a clinical practice update on lung cancer for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the update will cover and to whom it will apply. Registered stakeholders for the lung cancer update are invited to submit comments on the scope and may suggest clinical questions that could be answered in the update. Closing date for comments is 5th December 2008.
Consultation
The guidance focuses on the role of occupational therapy interventions and physical activity interventions in the promotion of mental wellbeing for older people. It is for NHS primary care and other professionals who have a direct or indirect role in, and responsibility for, promoting older people's mental wellbeing. This includes those working in local authorities and the wider public, private, voluntary and community sectors. It will also be relevant for carers and family members who support older people and may be of interest to older people themselves. The guidance complements and supports, but does not replace, NICE guidance on: supporting people with dementia and their carers in health and social care; managing depression in primary and secondary care; assessing and preventing falls in older people; obesity; commonly used methods to increase physical activity; physical activity and the environment; behaviour change and community engagement.
Guidance
Quick Reference Guide
Costing Report
Pain (chronic neuropathic or ischaemic) - spinal cord stimulation Technology Appraisal TA159 (22nd October 2008)
Spinal cord stimulation is recommended as a possible treatment for adults with chronic pain of neuropathic origin if they: continue to experience chronic pain (measuring at least 50 mm on a 0–100 mm visual analogue scale) for at least 6 months despite standard treatments, and have had a successful trial of spinal cord stimulation as part of an assessment by a specialist team. Treatment with spinal cord stimulation should only be given after the person has been assessed by a specialist team experienced in assessing and managing people receiving treatment with spinal cord stimulation.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Audit Support
Costing Template
Surgical site infection Clinical Guideline CG74 (22nd October 2008)
The advice in the NICE guideline covers: adults and children who are going to have a cut through the skin for an operation. It does not specifically look at: adults and children who are going to have an operation that does not involve a cut through the skin on the outside of the body; and adults and children who are going to have procedures involving thin tubes (called catheters) placed in blood vessels, tubes (called shunts) inserted into the body to divert fluid, thin flexible telescopes (called endoscopes) to view the inside of the body or metal pins used externally to treat broken bones. This guideline updates and replaces NICE technology appraisal guidance 24 (published April 2001).
NICE Guideline
Full Guideline
Full Guideline - Search Strategies
Full Guideline - Excluded Studies
Full Guideline - Evidence Tables
Quick Reference Guide
Understanding NICE Guidance
Costing Statement
Osteoporosis - primary prevention Technology appraisal TA160 (22th October 2008)
Whether or not a postmenopausal woman with osteoporosis is offered one of these drugs to prevent bone fractures will depend on her age, her bone density and how many risk factors for fracture and indicators of fragile bones she has. In principle, alendronate is recommended as a possible treatment for preventing bone fractures in postmenopausal women who have had osteoporosis diagnosed but have not had a fracture. If a woman can't take alendronate, risedronate and etidronate are recommended under certain circumstances as possible alternative treatments to prevent fractures. If a woman can't take alendronate or either risedronate or etidronate, then strontium ranelate is recommended under certain circumstances as a possible alternative treatment to prevent fractures. Raloxifene is not recommended as a treatment for preventing fractures in postmenopausal women with osteoporosis who have not had a fracture. The guidance says that women who are 75 or over may not need a bone scan to diagnose their osteoporosis.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Osteoporosis - secondary prevention including strontium ranelate Technology appraisal TA161 (29th October 2008)
Whether or not a postmenopausal woman who has had a bone fracture because of osteoporosis is offered treatment to prevent further fractures will depend on her age, her bone density and how many risk factors for fracture she has. Alendronate is recommended as a possible treatment for preventing bone fractures in postmenopausal women who have already had a fracture and have had osteoporosis diagnosed. If a woman can't take alendronate, risedronate and etidronate are recommended under certain circumstances as possible alternative treatments to prevent further fractures. If a woman can't take alendronate or either risedronate or etidronate, then strontium ranelate and raloxifene are recommended under certain circumstances as possible alternative treatments to prevent further fractures. If a woman can't take alendronate, or either risedronate or etidronate, or strontium ranelate, teriparatide is recommended under certain circumstances as a possible alternative treatment to prevent further fractures. Teriparatide is also recommended as a possible alternative treatment for a woman who has another fracture when she has been taking alendronate, risedronate or etidronate for 1 year (and her bone density has fallen). The guidance says that women who are 75 or over may not need a bone scan to diagnose their osteoporosis.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Management of long-term sickness absence and incapacity for work: consultation on the additional evidence (20th October 2008)
NICE was asked by the Department of Health (DH) to develop guidance for the NHS and other organisations in the public, community, voluntary and private sectors on: ‘the management of long-term sickness absence and incapacity'. In addition to the four evidence reviews and economic appraisal which were consulted on in May and June 2008 two reports and five expert papers have also been considered by the Programme Development Group (PDG) on long-term sickness absence and incapacity. Closing date for comments is 17th November 2008.
Consultation
Multiple myeloma - lenalidomide: appraisal consultation (28th October 2008)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of lenalidomide and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of lenalidomide. Closing date for comments is 18th November 2008.
Consultation
Evaluation Report
Interventional procedures consultation document - intraocular lens insertion for correction of refractive error, with preservation of the natural lens (28th October 2008)
Short-sightedness is the inability to see clearly at a distance. Eyesight can usually be corrected by wearing spectacles or contact lenses. Insertion of a clear plastic lens in front of the existing lens is a procedure that aims to improve vision in short-sightedness. Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultation document - laparoscopic cystectomy (28th October 2008)
Laparoscopic cystectomy involves removing the bladder using small cuts (also known as 'keyhole surgery'). In women, the bladder is removed through the wall of the vagina. In men, the bladder is removed with the prostate gland, through a small cut in the wall of the abdomen. The tubes that carry urine from the kidneys to the bladder (the ureters) may then be connected to a bag worn outside the body, or parts of the bowel can be used to make an artificial bladder which is drained by a connection to the abdomen wall or to the tube that carries urine out of the body (the urethra). Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultations document - extracorporeal photopheresis for Crohn’s disease (28th October 2008)
Crohn's disease is a chronic inflammatory disease that affects the gastrointestinal tract. It is sometimes associated with other complications such as skin rashes and arthritis. In extracorporeal photopheresis blood is removed from the patient, then the white blood cells are separated from the whole blood, treated with ultraviolet light and re-infused into the patient. Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultation document for percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia (28th October 2008)
Ventricular tachycardia is a life-threatening heart condition. It occurs when the electrical impulses controlling the heartbeat become erratic, causing the heart to beat too quickly. When this happens, the heart cannot efficiently pump blood around the body. Ventricular tachycardia, if left untreated, may cause sudden cardiac death. In percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation, selected areas on the outside of the heart are destroyed using heat, with the aim of preventing abnormal electrical impulses responsible for ventricular tachycardia from occurring. The procedure is carried out by inserting a special catheter into the sac around the heart and using it to deliver heat to selected areas of heart muscle where abnormal electrical impulses responsible for the ventricular tachycardia are detected. Closing date for comments is 25th November 2008.
Consultation
Interventional procedures consultation document - percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation (28th October 2008)
Laparoscopic cystectomy involves removing the bladder using small cuts (also known as 'keyhole surgery'). In women, the bladder is removed through the wall of the vagina. In men, the bladder is removed with the prostate gland, through a small cut in the wall of the abdomen. The tubes that carry urine from the kidneys to the bladder (the ureters) may then be connected to a bag worn outside the body, or parts of the bowel can be used to make an artificial bladder which is drained by a connection to the abdomen wall or to the tube that carries urine out of the body (the urethra). Closing date for comments is 25th November 2008.
Consultation
Strategies to prevent unintentional injuries among under 15s: draft scope consultation (3rd November 2008)
NICE is developing public health guidance (using the programme development process) to prevent unintentional injuries among children and young people aged under 15. Closing date for comments is 1st December 2008.
Consultation
Preventing unintentional injuries among under 15s in the home: consultation on the draft scope (3rd November 2008)
NICE is developing public health intervention guidance preventing unintentional injuries from fire, hot fluids, electric sockets and heat- generating appliances in the home among children and young people aged under 15. Closing date for comments is 1st December 2008.
Consultation
Preventing unintentional road injuries among under 15s: consultation on the draft scope (3rd November 2008)
NICE is developing public health intervention guidance on road design to prevent unintentional injuries among children and young people aged under 15. Closing date for comments is 1st December 2008.
Consultation
Appraising end of life medicines (4th November 2008)
NICE would like to receive comments on the proposal to issue supplemental advice to its Appraisal Committees, in the form of an amendment to its Guide to the Methods of Technology Appraisal. Closing date for comments is 10th December 2008.
Consultation
Critical illness rehabilitation: consultation on draft guidance (7th November 2008)
A clinical practice guideline on Critical illness rehabilitation is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations via this website. Closing date for comments is 5th December 2008.
Consultation
Lung cancer - update: consultation on the draft scope (7th November 2008)
NICE have been asked to develop a clinical practice update on lung cancer for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the update will cover and to whom it will apply. Registered stakeholders for the lung cancer update are invited to submit comments on the scope and may suggest clinical questions that could be answered in the update. Closing date for comments is 5th December 2008.
Consultation
Latest Implementation Tools (12th November 2008)
Surgical Site Infection Costing Statement
Pain - Spinal Cord Stimulation Costing Template and Audit Support
Mental Wellbeing and Older People Costing Report
Chronic Kidney Disease Guide to Resources
Identifying and supporting people most at risk of dying prematurely Slide Set
Surgical Site Infection Costing Statement
Pain - Spinal Cord Stimulation Costing Template and Audit Support
Mental Wellbeing and Older People Costing Report
Chronic Kidney Disease Guide to Resources
Identifying and supporting people most at risk of dying prematurely Slide Set
